JP2025503607A - セルピンペプチドおよびその使用方法 - Google Patents

セルピンペプチドおよびその使用方法 Download PDF

Info

Publication number
JP2025503607A
JP2025503607A JP2024540848A JP2024540848A JP2025503607A JP 2025503607 A JP2025503607 A JP 2025503607A JP 2024540848 A JP2024540848 A JP 2024540848A JP 2024540848 A JP2024540848 A JP 2024540848A JP 2025503607 A JP2025503607 A JP 2025503607A
Authority
JP
Japan
Prior art keywords
serpin
peptide
disease
condition
serpin peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024540848A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025503607A5 (cg-RX-API-DMAC7.html
Inventor
デイナ オースティン
コハヴァ ゲルバー
Original Assignee
セルピン ファーマ リミテッド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セルピン ファーマ リミテッド ライアビリティ カンパニー filed Critical セルピン ファーマ リミテッド ライアビリティ カンパニー
Publication of JP2025503607A publication Critical patent/JP2025503607A/ja
Publication of JP2025503607A5 publication Critical patent/JP2025503607A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
JP2024540848A 2022-01-05 2022-12-30 セルピンペプチドおよびその使用方法 Pending JP2025503607A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263266444P 2022-01-05 2022-01-05
US63/266,444 2022-01-05
PCT/US2022/082669 WO2023133078A2 (en) 2022-01-05 2022-12-30 Serpin peptides and methods of using the same

Publications (2)

Publication Number Publication Date
JP2025503607A true JP2025503607A (ja) 2025-02-04
JP2025503607A5 JP2025503607A5 (cg-RX-API-DMAC7.html) 2025-06-02

Family

ID=87074167

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024540848A Pending JP2025503607A (ja) 2022-01-05 2022-12-30 セルピンペプチドおよびその使用方法

Country Status (8)

Country Link
US (2) US20250161419A1 (cg-RX-API-DMAC7.html)
EP (1) EP4460322A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025503607A (cg-RX-API-DMAC7.html)
CN (1) CN118804758A (cg-RX-API-DMAC7.html)
AU (1) AU2022431253A1 (cg-RX-API-DMAC7.html)
CA (1) CA3247129A1 (cg-RX-API-DMAC7.html)
IL (1) IL314135A (cg-RX-API-DMAC7.html)
WO (1) WO2023133078A2 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016317726B2 (en) * 2015-08-28 2022-05-26 Serpin Pharma, Llc Methods for treatment of diseases
EP3402572B1 (en) * 2016-01-13 2022-03-16 Children's Hospital Medical Center Compositions and methods for treating allergic inflammatory conditions
CA3134610A1 (en) * 2018-04-09 2019-10-17 Yale University Bifunctional small molecules to target the selective degradation of circulating proteins
US20240342293A1 (en) * 2019-10-10 2024-10-17 Yale University Engineered antibodies as molecular degraders through cellular receptors
WO2021092050A1 (en) * 2019-11-04 2021-05-14 Azitra Inc Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
EP4789728A2 (en) * 2020-07-06 2026-08-12 Serpin Pharma, LLC Peptides and methods of using the same
BR112023016690A2 (pt) * 2021-02-22 2023-11-14 Univ Yale Degradadores bifuncionais direcionados e métodos usando os mesmos

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
STEFANO TOLDO ET AL.: "Low-Density Lipoprotein Receptor-Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infar", JACC: BASIC TO TRANSLATIONAL SCIENCE, vol. 2, no. 5, JPN6026019659, 2017, pages 561 - 574, ISSN: 0005860815 *
ZIXUAN WANG ET AL.: "α1-Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic", THE FASEB JOURNAL, vol. 36, no. 1, JPN6026019658, 2021, pages 22093 - 1, ISSN: 0005860814 *

Also Published As

Publication number Publication date
EP4460322A2 (en) 2024-11-13
CA3247129A1 (en) 2023-07-13
US20250161419A1 (en) 2025-05-22
CN118804758A (zh) 2024-10-18
WO2023133078A3 (en) 2023-08-17
EP4460322A4 (en) 2026-02-25
WO2023133078A2 (en) 2023-07-13
AU2022431253A1 (en) 2024-07-25
US20230406906A1 (en) 2023-12-21
IL314135A (en) 2024-09-01

Similar Documents

Publication Publication Date Title
US8158589B2 (en) Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)
CA2795390C (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
EP3058074B1 (en) Oral delivery of angiotensin converting enzyme 2 (ace2) or angiotensin-(1-7) bioencapsulated in plant cells
US8734775B2 (en) Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments
KR20150135242A (ko) C1 에스터라제 억제제 결핍과 관련된 장애의 예방 및 치료를 위한 c1-inh 조성물 및 방법
US20210008177A1 (en) Elapidae neurotoxin enhances opioid analgesic effect and inhibits opioid induced hyperalgesia and tolerance
CN111184856B (zh) 小分子多肽tp-7在制备治疗慢性肾脏病药物中的用途
US11779630B2 (en) Peptides and methods of using the same
JP5691049B2 (ja) 血管新生誘導活性及び抗菌活性を有する新規ポリペプチド並びにその医薬用途
JP5750766B2 (ja) 血管新生誘導活性及び抗菌活性を有するポリペプチドおよびそれを含有する創傷治療剤
KR101622524B1 (ko) 안정한 펙시가난 제제
US20190216901A1 (en) Acth prophylactic treatment of renal disorders
AU2016317574A1 (en) Compositions and methods for the treatment of neurodamage
AU2016373364A1 (en) Short synthetic peptide and uses thereof
US20230406906A1 (en) Serpin peptides and methods of using the same
HK40118659A (en) Serpin peptides and methods of using the same
KR20230034167A (ko) Kai1 폴리펩타이드를 포함하는 간 섬유화 억제용 약학 조성물 및 이의 용도
CN115279402A (zh) 对ve-ptp磷酸酶的抑制保护肾免于缺血-再灌注损伤
CN115335079A (zh) 基于外泌体递送nf-kb抑制剂的用途
HK40121727A (en) Serpin peptide derivatives and methods of using the same
US20250066452A1 (en) Synthetic amphipathic helical peptides and treatment methods using synthetic amphipathic helical peptides
KR20180120341A (ko) 폐 섬유증의 예방 또는 치료용 약학적 조성물
KR102115557B1 (ko) 폐 섬유증의 예방 또는 치료용 약학적 조성물
Xie et al. Exogenous IL-33 mitigates inflammatory responses by suppressing the NF-Κb signaling pathway, promoting blood-spinal cord barrier repair and neural functional recovery
EP4000627A1 (en) Treatment of abdominal aortic aneurysm after its clinical manifestation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241004

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250523

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250523

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260508

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260518

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260701

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260728